These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34211614)

  • 1. Hepatic Steatosis Index and Chronic Kidney Disease among Middle-Aged Individuals: A Large-Scale Study in Japan.
    Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Sakamoto K; Azuma M; Kokaze A
    Dis Markers; 2021; 2021():9941834. PubMed ID: 34211614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
    Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Watanabe A; Sakamoto K; Kokaze A
    BMC Nephrol; 2020 Nov; 21(1):471. PubMed ID: 33172399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos.
    Missikpode C; Kramer H; Cotler SJ; Durazo-Arvizu R; Lash JP; Kallwitz E; Cai J; Kuniholm MH; Rosas SE; Ricardo AC; Talavera GA; Raij L; Pirzada A; Daviglus ML
    BMC Nephrol; 2021 Sep; 22(1):302. PubMed ID: 34493216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
    Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
    Mantovani A; Morieri ML; Aldigeri R; Palmisano L; Masulli M; Bonomo K; Baroni MG; Cossu E; Cimini FA; Cavallo G; Buzzetti R; Mignogna C; Leonetti F; Bacci S; Trevisan R; Pollis RM; Cas AD; de Kreutzenberg SV; Targher G
    Diabetes Metab; 2024 Jan; 50(1):101497. PubMed ID: 37992857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.
    Zou Y; Zhong L; Hu C; Sheng G
    Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons.
    Cepoi V; Onofriescu M; Segall L; Covic A
    Int Urol Nephrol; 2012 Feb; 44(1):213-20. PubMed ID: 21360160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep and CKD in Chinese Adults: A Cross-Sectional Study.
    Li J; Huang Z; Hou J; Sawyer AM; Wu Z; Cai J; Curhan G; Wu S; Gao X
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):885-892. PubMed ID: 28389618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduction of serum aminotransferase levels is proportional to the decline of the glomerular filtration rate in patients with chronic kidney disease.
    Sette LH; Lopes EP
    Clinics (Sao Paulo); 2015 May; 70(5):346-9. PubMed ID: 26039951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China.
    Sun K; Lin D; Li F; Qi Y; Feng W; Yan L; Chen C; Ren M; Liu D
    BMJ Open; 2018 Jan; 8(1):e019097. PubMed ID: 29382678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study.
    Kaze FF; Halle MP; Mopa HT; Ashuntantang G; Fouda H; Ngogang J; Kengne AP
    BMC Nephrol; 2015 Jul; 16():96. PubMed ID: 26149764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.
    Long MT; Pedley A; Colantonio LD; Massaro JM; Hoffmann U; Muntner P; Fox CS
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1172-1180.e2. PubMed ID: 27046482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for chronic kidney disease increases with obesity: Health Survey for England 2010.
    MacLaughlin HL; Hall WL; Sanders TA; Macdougall IC
    Public Health Nutr; 2015 Dec; 18(18):3349-54. PubMed ID: 25743030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for chronic kidney diseases among an adult population.
    Fatema K; Abedin Z; Mansur A; Rahman F; Khatun T; Sumi N; Kobura K; Akter S; Ali L
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):534-41. PubMed ID: 23640626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease.
    Sabanayagam C; Wong TY; Liao J; Sethi S; Teo BW
    Clin Exp Nephrol; 2014 Dec; 18(6):919-24. PubMed ID: 24526413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study.
    Cicero AF; D'Addato S; Reggi A; Marchesini G; Borghi C;
    Metab Syndr Relat Disord; 2013 Dec; 11(6):412-6. PubMed ID: 23902132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.